First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control.
Fiche publication
Date publication
janvier 2016
Journal
Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BEDENNE Laurent, Dr BEN ABDELGHANI Meher, Pr GHIRINGHELLI François
Tous les auteurs :
Kotecki N, Hiret S, Etienne PL, Penel N, Tresch E, François E, Galais MP, Ben Abdelghani M, Michel P, Dahan L, Ghiringelli F, Bedenne L, Samalin E, Piessen G, Bennouna J, Peugniez C, El Hajbi F, Clisant S, Kramar A, Mariette C, Adenis A
Lien Pubmed
Résumé
This study aimed to identify predictors of tumor control (TC) in metastatic esophageal squamous cell carcinoma patients receiving first-line chemotherapy.
Mots clés
Antineoplastic Combined Chemotherapy Protocols, administration & dosage, Area Under Curve, Body Mass Index, Bone Neoplasms, secondary, Carcinoma, Squamous Cell, drug therapy, Cisplatin, Esophageal Neoplasms, drug therapy, Female, Fluorouracil, administration & dosage, Humans, Leucovorin, administration & dosage, Male, Middle Aged, Models, Biological, Organoplatinum Compounds, administration & dosage, Predictive Value of Tests, Prospective Studies, ROC Curve, Response Evaluation Criteria in Solid Tumors, Retrospective Studies, Serum Albumin, metabolism, Survival Rate, Treatment Outcome, Vinblastine, administration & dosage
Référence
Oncology. 2016 ;90(2):88-96